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Abstract
Background: Decompensated alcoholic liver disease is associated with abnormalities in protein synthesis. The
relationship of this to reprioritisation of hepatic export proteins and markers of the systemic inflammatory response is
unclear. We examined the longitudinal relationship between albumin and fibrinogen synthetic rates and disease
severity in decompensated alcoholic liver cirrhosis.
Patients and Methods: Hepatic protein synthetic rates were measured in patients with decompensated Childs
grade B or C alcohol-related cirrhosis using a validated technique, based on incorporation of deuterated
phenylalanine into the plasma pool of albumin and fibrinogen. As a measure of liver export protein reprioritisation,
we calculated the fibrinogen and albumin synthetic rates and the Acute Phase Protein Quotient (APPQ; the ratio of
these rates). Serum CRP and fibrin D-Dimer were recorded. Measurements were at baseline and on clinical
recovery at 4-6 weeks.
Results: 17 patients were studied. All patients had hypoalbuminaemia with elevated median C-reactive protein
(CRP), D-dimer, bilirubin and prothrombin times. Median albumin and fibrinogen synthetic rates were reduced
resulting in marginally increased APPQ. On follow up (n=10), there was reduction in Child-Pugh score (p<0.01),
plasma concentrations of Fibrin D-dimer (p<0.01), CRP (p<0.01), bilirubin (p<0.01) and prothrombin time (p<0.01).
Plasma albumin concentrations increased (p<0.01) and synthetic rates of both albumin (p<0.05) and fibrinogen
(p<0.10) increased marginally such that median APPQ remained similar.
Conclusion: Patients with decompensated alcohol-related cirrhosis had low albumin and fibrinogen synthetic
rates and raised CRP indicative of systemic inflammation. On recovery, albumin synthetic rate increased and CRP
levels fell, although albumin and fibrinogen synthetic rates remained below normal. Further studies assessing the
interaction between protein synthesis and systemic inflammation in chronic liver disease are indicated.
Keywords: Alcoholic liver disease; Albumin; Fibrinogen; Protein
synthesis; Systemic inflammation
Introduction
Patients with decompensated chronic liver disease often require
prolonged hospitalisation, during which time supportive management
is undertaken and specific therapies given with the aim of a gradual
improvement in liver function. Alcohol excess is an important cause of
liver cirrhosis and accounts for a significant proportion of hospital
admissions with this disease [1-3]. Liver cirrhosis is associated with
abnormalities in liver protein synthesis [4-7], a feature shared with
other disease states such as cancer [8-10].
Normal liver protein synthesis can be divided into that of fixed and
export proteins, and in total accounts for 15% to 25% of total body
protein synthesis [11,12]. The fixed hepatic proteins that include
structural cytoplasmic and mitochondrial proteins account for
approximately 50% of hepatic protein synthesis in normal subjects
with export protein synthesis accounting for the other 50% [11,13].
Of the export component, albumin synthesis (approximately 80%)
and fibrinogen synthesis (approximately 10%) are quantitatively the
most important [14,15]. These proteins play a key role in the systemic
inflammatory response, with albumin recognised as a negative acute
phase reactant and fibrinogen a positive acute phase reactant [16,17].
Previous work in cancer patients with an acute-phase response
suggests that the changes in plasma concentrations of these proteins in
certain disease states are due to reprioritisation of liver export protein
synthesis [4,16,18].
The low serum albumin characteristic of decompensated cirrhosis is
a strong prognostic indicator and is a parameter of the Child-Pugh
Scoring (CPS) system for assessing disease severity [19]. The
hypoalbuminaemia seen in cirrhosis has been reported to be associated
with a defective immune response, poor nutritional status and adverse
outcome [20]. Previously, it has been assumed that this low serum
albumin was due to reduced synthesis. However, studies in
hypoalbuminaemic cancer patients have reported an increased
albumin fractional synthetic rate [9,14,16].
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Fibrinogen is a substrate in the coagulation cascade and patients
with decompensated liver cirrhosis are known to exhibit complex
coagulation and fibrinolytic abnormalities [10,21]. Studies in patients
with cancer and chronic heart failure show that fibrinogen synthesis is
preserved or increased as part of the acute phase response [15,22,23].
To date, there are limited data on albumin and fibrinogen synthesis
rates in patients with decompensated alcohol related liver cirrhosis.
The aim of the present study was to examine the longitudinal
relationship between disease severity, total albumin and fibrinogen
synthetic rates and C-reactive protein (CRP; as a marker of systemic
inflammation) in patients with decompensated alcohol related liver
disease during a period of hospitalisation and out-patient follow-up.
Patients and methods
Study design and sample
Patients with Childs grade B or C alcohol related cirrhosis were
recruited following hospital admission with worsening ascites or
jaundice. Cirrhosis was confirmed by standard clinical and laboratory
data and imaging. No patient had evidence of GI bleeding or sepsis,
with all patients having negative blood and urine cultures, and no
evidence of bacterial peritonitis on diagnostic ascitic tap.
Routine measurement of haematological and biochemical
parameters, recording of clinical parameters and measurement of
albumin and fibrinogen synthetic rates were undertaken at baseline.
Out-patient follow-up measurement of these synthetic rates was
planned 4-6 weeks after the baseline measurements upon recovery
from the acute episode of decompensation. The study was approved by
the local Ethics Committee and informed consent was obtained in all
patients.
Study protocol
The present study used the rate of appearance of a known quantity
of deuterium labelled phenylalanine into circulating plasma albumin
and fibrinogen to estimate their respective hepatic synthetic rates.
Albumin and fibrinogen fractional synthetic rates were measured
using a validated phenylalanine flooding dose technique previously
described in detail [12,24-28]. Briefly, patients were asked to attend the
department after an overnight fast and an intravenous cannula was
placed into each antecubital fossa vein.
A solution containing 3500 mg of L-phenylalanine mixed with 350
mg [2H5]L-phenylalanine or 350 mg [2H8]L-phenyalanine in 0.5%
saline made up to 200 ml was then infused rapidly through a 0.2 μm
filter over 10 min through one of the cannulae.
The solution was prepared under sterile conditions, tested for
sterility and absence of pyrogens. Blood samples were drawn at 10, 20,
40, 60, 80, 120 min after the start of the infusion into EDTA tubes from
the contralateral arm, spun down in a cooled centrifuge at 4°C for 15
min, and stored at -80°C. As tracer will reside in the protein pool for
weeks [15], each subject received one of the two phenylalanine
isotopomers at baseline with the other at follow-up.
Sample preparation
The methods for the assessment of hepatic protein synthesis using
deuterated phenylalanine have been described elsewhere [26], but
briefly the rate of fibrinogen synthesis was reflected by the
incorporation of labelled phenylalanine into the plasma pool of
fibrinogen. For free phenylalanine analysis, 1 ml plasma samples were
diluted with 1 ml of deionised water.
Diluted samples were then deproteinised by ultrafiltration (30000
molecular weight cut-off Centrifree cone, Amicon, Gloucestershire,
UK) and acidified, and the amino acids were purified by cation
exchange. [2H5]-phenylalanine enrichment was measured by gas
chromatography-mass spectrometry (GC-MS) as its
ethoxycarbonyltrifluoroethyl ester derivative [27]. This derivative was
chosen as it gives good precision for [2H5]-phenylalanine analysis
while giving equivalent and improved precision for [2H8]-
phenylalanine analysis [28].
The fractional synthetic rate (FSR) was calculated by dividing the
rate of change of the appropriate phenylanine isotopomer enrichment
of albumin or fibrinogen by the area under the curve of precursor
enrichment versus time. The FSR corresponds to the percentage of the
intravascular albumin mass (IAM) synthesised per day (%/day). The
absolute or total synthetic rate (TSR) was calculated as the FSR × IAM
(plasma concentration × plasma volume) in mg/kg/day.
We have previously carried out simultaneous direct measurements
of albumin and fibrinogen TSR in normal fasted subjects [12]. From
these data, we derived the Acute Phase Protein Quotient (APPQ)
which is the ratio of the total synthetic rate (TSR) of fibrinogen/
albumin. This ratio is independent of plasma volume changes and
should be a sensitive measure of liver export protein reprioritisation. In
normal fasted subjects, normal median APPQ was measured at 0.14
(0.10-0.25).
Statistical analysis
Data are presented as median and range. Where appropriate, data
were tested for statistical significance using the Mann-Whitney U test,
and comparison of paired data was carried out using the Wilcoxon
signed rank test. Differences were considered significant when the
chance of their occurrence by sampling error was <1 in 20 (p<0.05).
All statistical analyses were performed in SPSS Version 18.0 (SPSS Inc).
Results
17 patients with decompensated alcohol related cirrhosis were
recruited to the study, with baseline characteristics shown in Table 1.
Median age was 50 years and the majority (n=15) of participants were
male. Three patients had been abstinent from alcohol for four weeks or
longer prior to admission.
Twelve patients fulfilled the common clinical criteria for alcoholic
hepatitis (alcohol excess within 4 weeks of admission, serum bilirubin
>80 μmol/l, AST and ALT <500 and absence of other causes of liver
disease), with ten having a modified discriminant function (mDF)>32
and two having a Glasgow alcoholic hepatitis score (GAHS) ≥ 9.
Sixteen patients had Childs grade C cirrhosis and one patient had
Childs grade B cirrhosis. Clinically detectable ascites was present in
sixteen of the seventeen patients. All patients had hypoalbuminaemia
and evidence of decompensated alcohol related liver cirrhosis with
evidence of a systemic inflammatory response as inferred by CRP
above the normal range. No patients had evidence of bacterial sepsis as
evidenced by negative blood, urine and ascitic fluid culture.
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All patients had median fibrin D-dimer, bilirubin and prothrombin
time above the normal range, but median fibrinogen was within the
normal range. With reference to total protein synthetic rates, the
median rates of both albumin and fibrinogen were below the normal
range such that their ratio (APPQ) was marginally elevated compared
with controls.
 Reference range Patients (n=17)
Age (years) N/A 50 (38-68)
Sex (M:F) N/A 15:2
BMI 20-25 26.8 (18.2-36.6)
Plasma volume (ml) 2700-3000 3154 (2189-3738)
Albumin (g/L) 35-56 25 (20-31)
Fibrinogen (g/l) 1.5-4.0 2.9 (1.8-4.6)
Fibrin D-dimer (ng/ml) 70-499 937 (384-1018)
C-reactive protein (mg/l) <10 31 (7-94)
Bilirubin (µmol) <20 147 (40-679)
Prothrombin time (secs) 9-12 22 (18-30)
Ascites (no/yes) N/A 16 / 17
Child-Pugh score 5-15 12 (9-13)
Albumin TSR (mg/kg/day) 208 (122-287) 48 (29-126)
Fibrinogen TSR (mg/kg/day) 28 (23-55) 11 (15-28)
APPQ Median (range) 0.14 (0.10-0.25) 0.17 (0.10-0.67)
TSR=Total Synthetic Rate
APPQ=Acute Phase Protein Quotient
Table 1: Admission characteristics of patients with decompensated
liver cirrhosis.
There was the suggestion of a negative correlation between baseline
CPS and albumin TSR although this did not reach statistical
significance (correlation coefficient -0.405, p=0.107). No correlation
was seen between baseline CPS and fibrinogen TSR (p=0.370), or
between either albumin or fibrinogen TSR and C-reactive protein
(p=0.844, p=0.978). There was no significant difference between the
sub-group with clinical alcoholic hepatitis and the other patients with
regard to albumin TSR (p=0.230), fibrinogen TSR (p=0.492) or APPQ
(p=1.00), although the C-reactive protein was slightly higher in the
alcoholic hepatitis group (p=0.08).
10 of the 17 patients attended for follow-up measurements. The
baseline and follow-up data of these patients are shown in Table 2. On
follow-up there was a significant clinical improvement as evidenced by
an improvement of CPS (p<0.01). There were also reductions in
plasma concentrations of Fibrin D-dimer (p<0.01), CRP (p<0.01),
bilirubin (p<0.01) and prothrombin time (p<0.01) and an increase in
plasma albumin (p<0.01). The total synthetic rates of both albumin
(p<0.05) and fibrinogen (p<0.10) increased marginally, such that the
median APPQ remained similar. Of the seven who failed to attend for
follow-up measurement, none had died within the 6 week follow-up
period after assessment of medical notes and discussion with their
general practitioner. We understand all seven had returned to drinking
alcohol to excess.
Admission
(n=10)
Recovery (n=10) p-
value
Plasma volume (ml) 3154 (2273-3738) 3123 (2218-3706) 0.017
Albumin (g/L) 25 (22-31) 32 (22-35) 0.007
Fibrinogen (g/l) 3.0 (1.8-4.6) 2.7 (1.6-4.2) 0.515
Fibrin D-dimer (ng/ml) 957 (864-1018) 878 (313-922) 0.008
C-reactive protein (mg/l) 27 (7-94) 8 (6-23) 0.005
Bilirubin (µmol) 143 (49-490) 61 (15-83) 0.005
Prothrombin time (secs) 22 (18-29) 19 (14-26) 0.007
Child-Pugh score 12 (9-13) 9 (6-13) 0.007
Albumin TSR (mg/kg/day) 61 (36-126) 96 (73-189) 0.011
Fibrinogen TSR (mg/kg/day) 15 (5-28) 23 (12-38) 0.093
APPQ Median (range) 0.17 (0.10-0.67) 0.22 (0.12-0.42) 1.000
TSR=Total Synthetic Rate
APPQ=Acute Phase Protein Quotient
Table 2: Admission and recovery characteristics of patients with
decompensated liver cirrhosis.
Discussion
The results of the present study show that, compared with normal
ranges, patients admitted with decompensated alcohol related liver
cirrhosis had a reduction in both their albumin and fibrinogen total
synthetic rates by 70% and 45% respectively. This was in the context of
a systemic inflammatory response as indicated by raised CRP. On
follow-up, both albumin and fibrinogen total synthetic rates increased
but remained significantly below the normal range (particularly the
albumin synthetic rate) in the context of a fall in both CRP and CPS.
The relative contributions of albumin and fibrinogen to export protein
synthesis remained similar. These longitudinal results suggest that in
addition to improved liver function, the systemic inflammatory
response may play a role in determining liver protein export synthesis.
It is of interest that the relationship between the acute phase
response and adverse outcome has become recognised in non-cirrhotic
disease states. Systemic-inflammation based scores, such as the
modified Glasgow Prognostic Score, have been shown to provide
accurate prognostic information in cancer patients independent of
tumour site [29,30]. Several studies have shown an association between
the acute phase response and adverse outcome across a range of cancer
types [29-31]. This association is also seen in other disease states such
as end-stage heart failure [22] and acute liver failure [32].
With reference to outcome in liver cirrhosis, Cazzaniga and
coworkers have reported that the systemic inflammatory response
syndrome (SIRS) is closely related to severity of liver disease in
cirrhotic patients as evidenced in the relationship with serum
bilirubin, INR and the Model for End-Stage Liver Disease (MELD)
score [33]. In their study, SIRS also predicted the development of
portal hypertension-related complications and was closely correlated
with in-hospital death. Shawcross and colleagues have suggested that
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the mediators of SIRS, including nitric oxide and pro-inflammatory
cytokines, may exacerbate the neuropsychological effects of the
hyperammonaemia seen in cirrhotic patients and may contribute to
progression of hepatic encephalopathy [34]. Also, Thabut and
coworkers reported that the presence of SIRS (with or without
infection) was an independent prognostic factor in patients with
cirrhosis and acute renal failure [35]. Whether moderation of the
systemic inflammatory response by anti-inflammatory drugs or other
means may improve outcome is unclear.
The value of CRP as a surrogate marker of SIRS and predictor of
outcome in cirrhosis has been a topic of increasing interest. Bota and
colleagues reported no significant difference in serum levels of acute
phase proteins between cirrhotic and non-cirrhotic critically ill
intensive care patients [36]. However Cervoni reported that in patients
with decompensated cirrhosis (with or without infection), persistently
elevated CRP concentration predicted short-term mortality
independent of MELD score, and was superior to the clinically-
assessed SIRS [37]. Also, Papp et al. [38] reported that CRP was a
reliable marker of bacterial infection in patients with cirrhosis,
although its accuracy decreased in advanced cirrhosis or in the
presence of ascites.
The limitations of our study include the fact that the diagnosis of
cirrhosis was based on clinical and laboratory data, without recourse to
liver biopsy. However this is standard practice in many centers due to
the complications of percutaneous biopsy, limited availability of
transjugular biopsy and debatable impact on management in this
patient group. We also did not measure formal SIRS scores, as not all
the required clinical parameters were recorded for all participants. Our
study numbers were also small and only 10 of the 17 recruited patients
attended for their follow-up study. All of the seven who failed to attend
for follow-up had been drinking heavily until their initial admission,
and we understand they had all started drinking again after discharge.
Additionally, we performed our follow up analysis after a recovery
period of 4-6 weeks, and while it was assumed that this time period
was sufficient to allow full recovery to baseline liver function, it may be
that a longer time interval would have seen a greater change in protein
synthetic rates. To our knowledge, this is the only longitudinal study
measuring hepatic export protein synthesis in decompensated alcohol-
related cirrhotic patients with evidence of systemic inflammation.
Follow up study with a larger patient group over a longer period of
follow up would be of value.
In conclusion, these results add to the growing body of evidence
concerning the important role of systemic inflammation in alcohol-
related liver cirrhosis and its relationship with liver function. It is
possible that moderation of the systemic inflammatory response is a
potential therapeutic target for improving liver function in patients
with decompensated alcoholic cirrhosis.
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